We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+7.05%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$11.4B
AUM Growth
+$1.76B
(+18%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
10.79%
Top 10 Holdings %
Top 10 Hldgs %
16.14%
Holding
579
New
177
Increased
129
Reduced
112
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$255M |
| 2 |
lululemon athletica
LULU
|
+$155M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$125M |
| 4 |
EPAM Systems
EPAM
|
+$124M |
| 5 |
Cigna
CI
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$244M |
| 2 |
Meta Platforms (Facebook)
META
|
+$239M |
| 3 |
Cisco
CSCO
|
+$133M |
| 4 |
Fortive
FTV
|
+$112M |
| 5 |
Nike
NKE
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.55% |
| 2 | Healthcare | 15.5% |
| 3 | Consumer Discretionary | 12.21% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Blink Charging
BLNK
$85.8M
| $818K | 0.01% |
+94,599
| New | +$998K |
|
|
AMPS
402
DELISTED
Altus Power
AMPS
| $804K | 0.01% |
146,741
-998,259
| -87% | -$7M |
|
|
DOC
403
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $799K | 0.01% |
53,529
-350,597
| -87% | -$5.29M |
|
404
Talkspace
TALK
$866M
| $798K | 0.01% |
1,147,821
-446,979
| -28% | -$354K |
|
405
Sweetgreen
SG
$656M
| $784K | 0.01% |
+100,000
| New | +$880K |
|
406
Avalo Therapeutics
AVTX
$1.01B
| $700K | 0.01% |
+1,667
| New | +$1.31M |
|
|
APLT
407
DELISTED
Applied Therapeutics
APLT
| $648K | 0.01% |
799,102
-468,950
| -37% | -$462K |
|
|
FITB
408
Fifth Third Bancorp
FITB
$52B
| $595K | 0.01% |
+22,339
| New | +$742K |
|
409
Mineralys Therapeutics
MLYS
$2.37B
| $587K | 0.01% |
+37,500
| New | +$631K |
|
|
ACB
410
Aurora Cannabis
ACB
$216M
| $572K | 0.01% |
82,000
| – | – |
|
411
CALL
Karyopharm Therapeutics
KPTI
$45.8M
| $562K | ﹤0.01% |
+9,634
| New | +$476K |
|
412
American Well
AMWL
$227M
| $560K | ﹤0.01% |
+11,856
| New | +$760K |
|
|
DZSI
413
DELISTED
DZS Inc. Common Stock
DZSI
| $535K | ﹤0.01% |
67,797
-67,796
| -50% | -$754K |
|
414
CubeSmart
CUBE
$9.2B
| $534K | ﹤0.01% |
11,559
-366,691
| -97% | -$16.4M |
|
|
SNCE
415
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $497K | ﹤0.01% |
88,319
+15,000
| +20% | +$114K |
|
416
AN2 Therapeutics
ANTX
$217M
| $478K | ﹤0.01% |
48,426
| – | – |
|
417
CALL
SCYNEXIS
SCYX
$47.1M
| $450K | ﹤0.01% |
+18,750
| New | +$249K |
|
418
Saia
SAIA
$9.45B
| $437K | ﹤0.01% |
+1,605
| New | +$428K |
|
419
Fulcrum Therapeutics
FULC
$280M
| $434K | ﹤0.01% |
+152,148
| New | +$1.36M |
|
420
Herc Holdings
HRI
$5.79B
| $418K | ﹤0.01% |
+3,670
| New | +$506K |
|
|
AUTL
421
Autolus Therapeutics
AUTL
$588M
| $394K | ﹤0.01% |
214,300
-1,250,000
| -85% | -$2.44M |
|
|
SONN
422
DELISTED
Sonnet BioTherapeutics
SONN
| $343K | ﹤0.01% |
+5,408
| New | +$875K |
|
423
Elutia
ELUT
$35.4M
| $324K | ﹤0.01% |
214,343
-35,657
| -14% | -$137K |
|
|
DCPH
424
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $315K | ﹤0.01% |
+20,400
| New | +$341K |
|
|
VAPO
425
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $310K | ﹤0.01% |
+59,524
| New | +$552K |
|
Similar funds
SAM
VIA
PPF
Alyeska Investment Group's Q1 2023 Portfolio in Review
As of Q1 2023, Alyeska Investment Group held 579 positions worth $11.4B, up 18% from $9.66B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Alyeska Investment Group deployed $1.23B of net new capital in Q1 2023, opening 177 new positions and adding to 129 existing holdings. Its largest new stake was lululemon athletica: 495,506 shares worth $180M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Salesforce, an estimated $244M trimmed.
- Alyeska Investment Group's largest Q1 2023 buy was lululemon athletica: 495,506 shares worth $180M.
- Alyeska Investment Group added most to Adobe in Q1 2023, an estimated $255M increase.
- Alyeska Investment Group's biggest Q1 2023 reduction was Salesforce, cutting an estimated $244M.
- Alyeska Investment Group fully exited Domino's in Q1 2023, selling an estimated $95.7M.
- Alyeska Investment Group's ten largest holdings make up 16% of its $11.4B portfolio in Q1 2023.
- Alyeska Investment Group opened 177 new positions and closed 139 in Q1 2023.
- Alyeska Investment Group's portfolio value rose 18% quarter-over-quarter to $11.4B.
Based on Alyeska Investment Group's 13F filing for Q1 2023, filed 15 May 2023.